CXCL13 and systemic sclerosis: Median CXCL-13 serum levels were significantly higher in SSc patients compared to HC [124.97 ng/ml (IQR 82.78–212.92) vs 76.55 ng/ml (IQR 48.58–105.18), p < 0.001].